Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank C Cackowski

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
The Prostate|August 27, 2019
Detection and isolation of disseminated tumor cells in bone marrow of patients with clinically localized prostate cancerFrank C Cackowski, Yugang Wang, Joseph T Decker, et al.
Translational Oncology|February 22, 2023
HER2 as a potential therapeutic target on quiescent prostate cancer cellsKenji Yumoto, Jibraan Rashid, Kristina G Ibrahim, et al.
Oncotarget|May 14, 2016
The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancerYusuke Shiozawa, Janice E Berry, Matthew R Eber, et al.
Oncotarget|June 10, 2017
Correction: The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancerYusuke Shiozawa, Janice E Berry, Matthew R Eber, et al.
Cancer Research Communications|September 25, 2024
Peripheral Blood IFN Responses to Toll-Like Receptor 1/2 Signaling Associate with Longer Survival in Men with Metastatic Prostate Cancer Treated with Sipuleucel-TMichael C Brown, Vincent M D'Anniballe, David Boczkowski, et al.
Cancer Research|February 13, 2018
CXCL12γ Promotes Metastatic Castration-Resistant Prostate Cancer by Inducing Cancer Stem Cell and Neuroendocrine PhenotypesYounghun Jung, Frank C Cackowski, Kenji Yumoto, et al.
Cancer Research|November 16, 2021
Correction: CXCL12γ Promotes Metastatic Castration-Resistant Prostate Cancer by Inducing Cancer Stem Cell and Neuroendocrine PhenotypesYounghun Jung, Frank C Cackowski, Kenji Yumoto, et al.
Cancer Research Communications|June 10, 2024
Race-Related Differences in Sipuleucel-T Response among Men with Metastatic Castrate-Resistant Prostate CancerElisabeth I Heath, Archana Thakur, Wei Chen, et al.
Translational Oncology|March 29, 2020
Wnt Signaling Drives Prostate Cancer Bone Metastatic Tropism and InvasionYugang Wang, Udit Singhal, Yuanyuan Qiao, et al.
International Journal of Molecular Sciences|January 11, 2022
Multigene Profiling of Circulating Tumor Cells (CTCs) for Prognostic Assessment in Treatment-Naïve Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)Zachery R Reichert, Tadas Kasputis, Srinivas Nallandhighal, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
The Prostate|August 27, 2019
Detection and isolation of disseminated tumor cells in bone marrow of patients with clinically localized prostate cancerFrank C Cackowski, Yugang Wang, Joseph T Decker, et al.
Translational Oncology|February 22, 2023
HER2 as a potential therapeutic target on quiescent prostate cancer cellsKenji Yumoto, Jibraan Rashid, Kristina G Ibrahim, et al.
Oncotarget|May 14, 2016
The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancerYusuke Shiozawa, Janice E Berry, Matthew R Eber, et al.
Oncotarget|June 10, 2017
Correction: The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancerYusuke Shiozawa, Janice E Berry, Matthew R Eber, et al.
Cancer Research Communications|September 25, 2024
Peripheral Blood IFN Responses to Toll-Like Receptor 1/2 Signaling Associate with Longer Survival in Men with Metastatic Prostate Cancer Treated with Sipuleucel-TMichael C Brown, Vincent M D'Anniballe, David Boczkowski, et al.
Cancer Research|February 13, 2018
CXCL12γ Promotes Metastatic Castration-Resistant Prostate Cancer by Inducing Cancer Stem Cell and Neuroendocrine PhenotypesYounghun Jung, Frank C Cackowski, Kenji Yumoto, et al.
Cancer Research|November 16, 2021
Correction: CXCL12γ Promotes Metastatic Castration-Resistant Prostate Cancer by Inducing Cancer Stem Cell and Neuroendocrine PhenotypesYounghun Jung, Frank C Cackowski, Kenji Yumoto, et al.
Cancer Research Communications|June 10, 2024
Race-Related Differences in Sipuleucel-T Response among Men with Metastatic Castrate-Resistant Prostate CancerElisabeth I Heath, Archana Thakur, Wei Chen, et al.
Translational Oncology|March 29, 2020
Wnt Signaling Drives Prostate Cancer Bone Metastatic Tropism and InvasionYugang Wang, Udit Singhal, Yuanyuan Qiao, et al.
International Journal of Molecular Sciences|January 11, 2022
Multigene Profiling of Circulating Tumor Cells (CTCs) for Prognostic Assessment in Treatment-Naïve Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)Zachery R Reichert, Tadas Kasputis, Srinivas Nallandhighal, et al.
Pageof 5